Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Migraine

Free Subscription 06.04.2026 2 BMC Neurol 1 Brain Res 4 Cephalalgia 5 Headache 1 Nat Rev Neurol 1 Neurologia (Engl Ed) 2 Rev Neurol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Neurol

1. KILICASLAN F, Altunisik E, Firat YE, Lule KO, et al
   ABO blood group distribution in migraine patients; the relationship of phenotypes with migraine subtypes, clinical features, and white matter lesions: a retrospective case-control study.
   BMC Neurol. 2026 Apr 2. doi: 10.1186/s12883-026-04872.
   PubMed        
   
   
2. YE W, Fan Y, Liu J, Xu X, et al
   Efficacy and safety of rimegepant in Chinese women with pure menstrual migraine: a retrospective observational study.
   BMC Neurol. 2026 Apr 2. doi: 10.1186/s12883-026-04859.
   PubMed        
   
   

   
   Brain Res

3. O'HARE L, Kalaj J, Focker J
   People who play games regularly are no more robust to unpleasant images compared to those who do not in preparation for brain research.
   Brain Res. 2026;1880:150222.
   PubMed         Abstract available
   
   

   
   Cephalalgia

4. ZHUANG ZA, Thuraiaiyah J, Kokoti L, Moreno RD, et al
   Migraine induced by vascular K(ATP) channel activation is independent of HCN channel activity: A randomised controlled trial with translational validation.
   Cephalalgia. 2026;46:3331024261431770.
   PubMed         Abstract available
   
   
5. HAKIMZADEH Z, Chaudhry BA, Al-Khazali HM, Christensen RH, et al
   Molecular triggers of migraine aura: A systematic review of human pharmacological provocation studies.
   Cephalalgia. 2026;46:3331024261429112.
   PubMed         Abstract available
   
   
6. GAGO-VEIGA AB, Lopez-Rodriguez AB, Sanchez Jimenez M, Iglesias Rubio A, et al
   Atogepant for migraine in real-world clinical practice: Insights from a large multicentre study in a treatment-resistant population (GEMA project).
   Cephalalgia. 2026;46:3331024261431337.
   PubMed         Abstract available
   
   
7. 
   Corrigendum to: International Headache society evidence-based guidelines on the use of non-invasive neuromodulation devices for the acute and preventive treatment of migraine.
   Cephalalgia. 2026;46:3331024261435762.
   PubMed        
   
   

   
   Headache

8. GARCIA-CASTILLO MC, Sierra-Mencia A, Caronna E, Toledo-Alfocea D, et al
   Evaluation of the effectiveness and safety of anti-CGRP monoclonal antibodies in patients with migraine and autoimmune diseases: IMMUNO-CGRP study.
   Headache. 2026 Apr 1. doi: 10.1111/head.70086.
   PubMed         Abstract available
   
   
9. JUNG DE, Cho S, Ha WS, Shin HJ, et al
   Chronotype in migraine and tension-type headache: A population study.
   Headache. 2026 Mar 28. doi: 10.1111/head.70070.
   PubMed         Abstract available
   
   
10. VANDERPLUYM JH
    The status of status migrainosus: Exploring conceptual and operational limitations of International Classification of Headache Disorders criteria.
    Headache. 2026 Mar 27. doi: 10.1111/head.70095.
    PubMed        
    
    
11. ROBBLEE J, Smith JH, Ahmad S, Geiser R, et al
    Redefining status migrainosus: A narrative review.
    Headache. 2026 Mar 27. doi: 10.1111/head.70075.
    PubMed         Abstract available
    
    
12. MOSKATEL LS, Slusky DJG
    The state of insurance coverage of calcitonin gene-related peptide-targeted medications and its impact on the implementation of the American Headache Society's 2024 consensus statement: An interrupted time-series analysis.
    Headache. 2026;66:801-812.
    PubMed         Abstract available
    
    

    
    Nat Rev Neurol

13. AYATA C, Hougaard A, Schiff SJ, Ferrari MD, et al
    Tsunamis hiding in plain sight: spreading depression in clinical neurology.
    Nat Rev Neurol. 2026 Mar 11. doi: 10.1038/s41582-026-01191.
    PubMed         Abstract available
    
    

    
    Neurologia (Engl Ed)

14. SOBRINO F, Zorro M, Bedoya MT, Ramos ML, et al
    Real-world healthcare resource utilisation for migraine: analysis of an administrative database in Colombia.
    Neurologia (Engl Ed). 2026 Mar 28:502008. doi: 10.1016/j.nrleng.2026.502008.
    PubMed         Abstract available
    
    

    
    Rev Neurol

15. GINE-CIPRES E, Torres-Ferrus M, Gallardo VJ, Alpuente Ruiz A, et al
    Optimizing Chronic Migraine Care: The Impact of Advanced Practice Nurse Involvement in OnabotulinumtoxinA Administration.
    Rev Neurol. 2026;81:45618.
    PubMed         Abstract available
    
    
16. CERNIGLIARO F, Gallo C, Alessi G, Messina LM, et al
    Pediatric Migraine Aura Status and Cortical Laminar Necrosis: A Clinical Case and a Narrative Review.
    Rev Neurol. 2026;81:47684.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Migraine is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum